HSA Approval

MEDICAP CAPSULE 250 mg

Approval Number

SIN05454P

Drug Name

Product Name

MEDICAP CAPSULE 250 mg

Approval Date

February 19, 1991

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

M01AG01

ATC Item Name

mefenamic acid

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD

Active Ingredients

Ingredient Name

MEFENAMIC ACID

Strength

250 mg

Drug MonographMefenamic acid

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

MEDICAP CAPSULE 250 mg - HSA Approval | MedPath

AI-Powered Research

Premium Access

MEDICAP CAPSULE 250 mg

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal